Müller J, Schrader M, Schrader A J, Höpfner M, Zengerling F
Klinik für Urologie, Universitätsklinikum Ulm, Prittwitzstraße 43, 89075 Ulm, Deutschland.
Urologe A. 2012 Mar;51(3):331-40. doi: 10.1007/s00120-012-2834-5.
Positron emission tomography/computed tomography (PET/CT) is widely used for imaging urological neoplasms. This overview should help the urologist actively involved in oncology to assess the value of PET or PET/CT in each tumor entity. Besides prostate, testicular, renal, and bladder cancer less common urological malignancies like penile carcinoma and retroperitoneal masses are discussed. Differences in using PET/CT for primary diagnosis, staging, or restaging are outlined separately. Appropriate indications for the use in clinical practice are cited.
正电子发射断层扫描/计算机断层扫描（PET/CT）广泛应用于泌尿系统肿瘤的成像。本综述应有助于积极参与肿瘤学研究的泌尿外科医生评估PET或PET/CT在每种肿瘤实体中的价值。除了前列腺癌、睾丸癌、肾癌和膀胱癌外，还讨论了阴茎癌和腹膜后肿块等较罕见的泌尿生殖系统恶性肿瘤。分别概述了PET/CT在原发性诊断、分期或再分期中的应用差异。文中列举了在临床实践中使用PET/CT的适当适应症。
